Genitourinary (GU) cancers encompass an array of diseases requiring an equally wide range of treatments. At Maroone Cancer Center, people with cancers of the prostate, bladder or kidneys, as well as adrenal, penile or testicular cancer, receive the most compassionate, comprehensive care featuring the latest diagnostic and treatment innovations provided by our multidisciplinary team of experts.
Diagnosing GU Cancers
Our specialists use state-of-the-art imaging, as well as advanced endoscopic procedures and biopsy protocols, to diagnose and stage GU cancers. High-tech multiparametric MRI, combined with systematic biopsy, can aid in prostate cancer staging and guide treatment decisions.
Furthermore, for some patients, Maroone Cancer Center experts employ sophisticated molecular tests to help determine the aggressiveness of prostate cancer and gauge whether a man requires immediate curative treatment or can safely undergo active surveillance to monitor the cancer.
Our specialists also offer high-tech molecular testing that identifies specific genetic signatures in advanced GU cancers (such as those affecting the prostate, bladder and kidneys) that make them amenable to treatment with targeted therapies and immunotherapy.
Surgery is a primary treatment for all GU cancers. Oftentimes, our surgeons can perform these operations using minimally invasive robot-assisted or laparoscopic techniques, which improve patient recovery while producing high-quality oncologic outcomes.
The Maroone Cancer Center offers the latest in radiation treatments and chemotherapy regimens, as well as a variety of antiandrogen drugs for advanced prostate cancer. We provide the latest in targeted therapies and immunotherapy to treat several advanced GU cancers. Our specialists also provide comprehensive care to manage quality-of-life issues that may arise during treatment of GU cancers.
Our multidisciplinary team of surgeons, radiation and medical oncologists, pathologists, nutritionist, geneticists, psychologist and other providers collaborate daily and meet periodically as a tumor board to discuss complex cases. In this way, we can offer the best treatment approach tailored for each individual patient’s unique characteristics.
Radiation for Genitourinary Cancers
Maroone Cancer Center offers advanced radiation regimens that treat prostate and bladder cancers while preserving quality of life.
Radiation plays a major part in prostate cancer treatment and an evolving role in treating certain types of bladder cancer. Radiation therapy for these genitourinary cancers requires precision and skill to effectively kill the cancer while minimizing exposure to adjacent tissues.
Employing the latest in advanced technology and treatment protocols, Maroone Cancer Center radiation oncologists can effectively treat localized prostate cancer in far fewer sessions, providing a major convenience to many of our patients. And, based on a growing body of research, our specialists now offer bladder-preserving chemoradiation regimens as an alternative to surgery for locally advanced bladder cancer.
SBRT for Prostate Cancer
Conventional external-beam radiation therapy (EBRT) for prostate cancer consists of as many as 40 to 45 treatments (known as fractions) given daily over eight to nine weeks. More recently, moderately hypofractionated regimens — involving 20 to 28 fractions given in higher doses over four to six weeks — have been shown to be as safe and effective at treating localized prostate cancer as conventional EBRT.
Now, at Maroone Cancer Center, that treatment duration has been reduced even further with stereotactic body radiation therapy (SBRT). In this approach, high-dose radiation is administered in only five fractions every other day. Our specialists use the state-of-the-art Varian Edge® system to target the radiation precisely on the prostate treatment area, thereby limiting radiation exposure to the bladder, rectum and other nearby tissues and reducing side effects.
The Maroone Cancer Center experts consider SBRT as an option for men with cancer confined to the prostate, whereas moderate hypofractionation is used for men with prostate cancer that has spread to nearby lymph nodes, according to radiation oncologist Eva Suarez, MD.
Research suggests that SBRT can achieve cancer control rates comparable to those of conventional EBRT, but with more convenience for patients.
Radiation for Bladder Cancer
Historically, most men and women with muscle-invasive bladder cancer have required surgery to remove the bladder (cystectomy). Afterward, patients require a urostomy or an internal pouch made of small intestine to store urine and remove it from the body.
Appointments & Locations
To schedule a consultation, please call toll-free 877.463.2010. You can also make an appointment online.
You can now stay connected to your healthcare team through virtual visits, using your smartphone, tablet or computer.
Why go virtual? It's an easy, convenient and secure way to see your provider face-to-face without having to leave home. This saves you travel time, parking fees and time spent in the waiting room — and you can also have a loved one or caregiver join you. If appropriate, you can also get a prescription sent to the pharmacy of your choice.
Many insurance companies cover the cost of virtual visits, so check with your insurance company ahead of time. Interested in getting started? Call your provider to find out what virtual visit options are available.